University of Ioannina
Μελέτη του ρόλου των πρόδρομων ενδοθηλιακών κυττάρων (EPCs) στην αθηρωματική νόσο
Abstract
dc:descriptionIt is known that, platelets play a major role in hemostasis, inflammation and angiogenesis. Endothelial progenitor cells (EPCs) are a population of pluripotent stem cells which have the ability to differentiate into mature endothelial cells (ECs). EPCs contribute significantly in the regeneration of the vascular endothelium and neovascularization. Furthermore, they express surface antigens CD34, CD133 and KDR. CD34 and CD133 are markers of progenitor cells, whereas KDR identifies cells with endothelial phenotype. Consequently, the definition of EPCs is complex due to the absence of a unique specific cell marker. Furthermore, a specific and sensitive method for the characterization and identification of EPCs has not yet been developed in the international scientific community. However, several types of circulating EPCs, depending on the method of isolation and culture, have been described in bibliography. These include colony forming unit-Hill (CFU-Hill) cells, and circulating angiogenic cells (CACs) which are called early EPCs, as well as late-outgrowth endothelial progenitor cells (OECs) that are late EPCs. In the present study, we initially developed methods for the isolation and culture of EPC populations for the first time in our laboratory. Then, we wanted to investigate the potential effect of the above types of EPCs on platelet activation in vitro.Initially, peripheral blood mononuclear cells were isolated and cultured under different conditions to lead to the formation of CFU-Hill and CACs cells. Moreover, CD34+ cells were isolated from cord blood mononuclear cells and appropriately cultured for 30-days for differentiation into OECs. Then, we performed characterization and identification of the above types of EPCs using light inverted microscope, flow cytometry, and finally confocal microscopy. It was found that, CFU-Hill cells formed colonies with a defined central cluster of round cells and elongated spindle-like cells in the periphery. CACs were rounded cells whereas some of them acquired spindle-shaped morphology. OECs better resemble mature endothelial cells from umbilical cord (HUVECs) since they display typical cobblestone morphology and they have high proliferative capacity. Finally, CD34+ cells appeared to be small with round shape. Next, we performed the characterization of the three types of EPCs for the expression of cell surface antigens. CFU-Hill cells expressed CD34, KDR, CD133. Moreover, they expressed the panleukocyte marker CD45 and the monocyte marker CD14, indicating their hematopoietic nature. Finally, they expressed CD31, a specific endothelial antigen. Similarly, CACs expressed CD34, KDR, CD133, CD31 including CD45 and CD14, suggesting that these cells exhibit haematopoietic characteristics. In general, OECs showed expression of CD34, KDR, CD31 and only a small percentage expressed the immature marker CD133. On the other hand, OECs did not express at all the hematopoietic markers CD14 and CD45, showing that these cells exhibit strong endothelial phenotype. An important finding is that, the endothelial phenotype of OECs appears to be much stronger as cell passage is increased. Finally, we characterized EPCs performing experiments with confocal microscopy. CFU-Hill were found positive for DiI-acetylated LDL (DiI-ac-LDL) uptake and FITC-lectin binding. CACs stained positive with both ac-LDL and lectin. Furthermore, CACs stained with von Willebrand factor (vWF). Similarly, OECs stained with ac-LDL, lectin, and vWF.Since we performed the characterization and identification of EPCs, the effect of those cells and their supernatant on washed platelet aggregation was studied with the light transmittance aggregometry method. CD34+ and HUVECs cells and their supernatant were also studied. Collagen, thrombin and trap14 were used as platelet agonists. Both the CFU-Hill cells and their supernatant did not inhibit platelet aggregation in the presence of collagen or thrombin. Similarly, CACs cells and their supernatant did not exhibit any inhibitory activity on platelet aggregation induced by collagen or Trap14. On the other hand, OECs cells and their supernatant inhibited platelet aggregation induced by collagen or Trap14. The inhibitory effect of OECs on platelet aggregation was similar to that induced by HUVECs, since OECs express strong endothelial phenotype. It was found that, OECs cells, unlike early EPCs exhibit increased expression of endothelial nitric oxide synthase (eNOS) and secrete various antiplatelet factors, such as nitric oxide (NO) and prostaglandin I2 (PGI2). Therefore, the supernatant of OECs is able to inhibit platelet aggregation. The increased degree of endothelial phenotype was found to be associated with higher percentage of antiplatelet activity. Furthermore, OECs cells inhibited platelet aggregation in a dose- and time-dependent manner. Finally, a very important original finding of this study is that the OECs cells and their supernatant exhibited higher inhibition on washed platelet aggregation in the presence of Trap14 compared to collagen. This phenomenon may be due to the fact that EPCs and particularly late EPCs express PAR-1 receptor. Both CD34+ cells and their supernatant did not inhibit platelet aggregation by thrombin. Conclusively, only OECs cells and their supernatant showed inhibition of platelet aggregation displaying strong antiplatelet activity. Therefore, we wanted to study further the effect of OECs and their supernatant on platelet activation using flow cytometry.We studied the effect of OECs and their supernatant on platelet activation induced by agonist ADP. Platelet activation was evaluated by determining the integrin-receptor αIIbβ3 membrane expression (PAC-1-FITC binding) and P-selectin membrane expression (CD62P-PE). Platelets were stained with platelet marker CD61-PerCP and OECs with endothelial marker CD31-PE. The effect of HUVECs cells and their supernatant, as well as CD34+ cells on platelet activation was also studied. It was found that, platelets that are not attached to CD34+, OECs and HUVECs cells, are activated. OECs and HUVECs cells, as well as their supernatant inhibited non-adherent platelet activation. On the contrary, CD34+ cells and their supernatant did not inhibit non-adherent platelet activation. Platelet activation with ADP induces platelet adherence to OECs, CD34+ and HUVECs cells. It was observed that, platelets that are adherent either to OECs or to HUVECs cells are not activated. The above phenomenon was not noticed in CD34+ cells.In summary, the present study shows for the first time that OECs cells and their supernatant exhibit potent antiplatelet activity. The importance of the above findings on the mechanisms of atheromatosis remain under investigation.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Chantzichristos, Vasileios
- Χαντζηχρήστος, Βασίλειος
Subjects
dc:subject × 28- Πρόδρομα ενδοθηλιακά κύτταρα
- Ενδοθηλιακά κύτταρα
- Αιμοπετάλια
- Αθηρωματική νόσος
- Καλλιέργεια κυττάρων
- Συσσωρευομετρία οπτικής διαπερατότητας
- Κυτταρομετρία ροής
- Κυκλοφορούντα αγγειογενετικά κύτταρα
- Προχωρημένης ωρίμανσης πρόδρομα ενδοθηλιακά κύτταρα
- Ομφάλιος λώρος
- Endothelial progenitor cells
- Endothelial cells
- Platelets
- Atheromatous disease
- Cell culture
- Light transmittance aggregometry
- Flow cytometry
- Circulating angiogenic cells
- Late-outgrowth endothelial progenitor cells
- Cord blood
- Φυσικές Επιστήμες
- Βιολογία
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες Υγείας
- Natural Sciences
- Biological Sciences
- Medical and Health Sciences
- Health Sciences
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/34724